EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to Anixa Biosciences, Inc.'s (NASDAQ:ANIX) breast cancer vaccine technology.
Cleveland Clinic has exclusively licensed the patent and others related to this technology to Anixa Biosciences. The patent will expand the scope of immunogenic compositions utilized in Anixa's breast cancer vaccine.
Also Read:
This newly allowed patent covers methods of immunizing patients against breast cancer by administering an immunogenic composition containing the human α-lactalbumin protein, a protein typically found in breast tissue during lactation but also expressed in certain breast cancers.
Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences, stated, "This patent strengthens our intellectual property portfolio and highlights the novelty of our breast cancer vaccine. Our intellectual property portfolio includes multiple issued and pending patents in the U.S. and international jurisdictions."
In March, the USPTO issued a Notice of Allowance for a key patent application covering Anixa Biosciences ovarian cancer vaccine technology.
The patent includes broad claims related to methods of eliciting an immune response targeting the Anti-Mullerian Hormone Receptor, Type II (AMHR2), a target for ovarian cancer prevention and treatment.
Anixa's ovarian cancer vaccine is being developed in collaboration with Cleveland Clinic and the National Cancer Institute.
The allowed claims include methods of administering an immunogenic composition comprising a nucleic acid encoding the AMHR2 polypeptide, specifically the extracellular domain of human AMHR2, to elicit an AMHR2-specific immune response.
Price Action: ANIX stock closed at $2.38 on Tuesday.
Read Next:Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.
Get the latest stock analysis from Benzinga?
This article EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Why CrowdStrike (CRWD) Stock Is Falling Today
Shares of cybersecurity company CrowdStrike (NASDAQ:CRWD) fell 5.5% in the afternoon session after the company reported mixed first quarter 2025 (Q1 FY-26) results: its revenue guidance for next quarter slightly missed and its full-year revenue guidance was just in line with Wall Street's estimates. On the other hand, CrowdStrike beat convincingly on operating profit. Looking ahead, guidance was solid. The company's EPS guidance for next quarter topped analysts' expectations, and its full-year EPS guidance slightly exceeded Wall Street's estimates as well. Overall, this was a mixed quarter and not enough for the high expectations around the stock (as evidenced by the 52-week high right before reporting and a 40+% stock price appreciation year-to-date before the print). The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy CrowdStrike? Access our full analysis report here, it's free. CrowdStrike's shares are very volatile and have had 20 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 11 months ago when the stock dropped 14.7% following a global technology outage. The outage was caused by a faulty update deployed by CrowdStrike to computers running the Microsoft Windows operating system. CrowdStrike clarified that the issue wasn't caused by "a security incident or cyberattack." CEO George Kurtz noted on the social media platform X (formerly called Twitter) that "the issue has been identified, isolated, and a fix has been deployed." However, the issue had far-reaching consequences, affecting systems in industries delivering critical services, including hospitals, banks, and airports. CRWD stock's decline suggested markets might be struggling to understand the long-term implications of the issue, especially as it relates to CrowdStrike maintaining its dominance in the highly competitive cybersecurity space, which often permits little to no room for mistakes. Wedbush analyst Dan Ives provided insights on how this might play out, adding, "It could create opportunity for some competitive displacements, but this will take time to determine the path of CIOs and companies looking ahead and related legal actions related to this outage." CrowdStrike is up 33% since the beginning of the year, and at $461.84 per share, it is trading close to its 52-week high of $488.76 from June 2025. Investors who bought $1,000 worth of CrowdStrike's shares 5 years ago would now be looking at an investment worth $4,812. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Yahoo
34 minutes ago
- Yahoo
Germany and Poland plan closer cooperation despite recent election
German Foreign Minister Johann Wadephul and his Polish counterpart Radosław Sikorski plan to advance cooperation between their two countries despite the victory of eurosceptic Karol Nawrocki in the Polish presidential election. "I assume that we will continue to work together very closely and amicably," Wadephul said on Wednesday during a meeting with Sikorski in Berlin. "Our ties are so strong that democratic elections here or there do not call them into question in any way." The cooperation also applies to France within the Weimar Triangle, for example in coordinating support for Ukraine, Wadephul said. The trilateral group, established in 1991, includes France, Germany and Poland, and is designed to promote cooperation among the three. Nawrocki, who was backed by the conservative nationalist Law and Justice party (PiS), had campaigned with anti-German and anti-European rhetoric. But Wadephul said the German-Polish partnership is so close and solid that he has no doubts that joint future and defence projects could be realized. Poland, he said, had held democratic elections. Germans and Poles are friends, "and we want to continue that," the German foreign minister added. Sikorski: Government controls foreign policy Sikorski described it as a sign of democracy that a representative of the opposition had won the presidential election in Poland. Similar to Germany, the president in Poland is not the head of government but a representative of the country abroad. He implements the policies set by the government. While the Polish president has more powers than the German president, including a veto right, "foreign policy is the responsibility of the government," Sikorski said. Wadephul: Defence and infrastructure are key topics Wadephul highlighted European air defence as a security guarantee for citizens and the advancement of European defence cooperation as key areas for expanding collaboration. This, he said, requires "concrete projects, industrial partnerships and political will that does not stop at national borders." A resilient Europe, he added, also requires efficient infrastructure. Roads, railways and bridges are "not just transport routes but lifelines for our security, including between Germany and Poland." At the same time, these investments would tangibly improve the daily lives of people in Poland, Germany and across Europe, he said.
Yahoo
43 minutes ago
- Yahoo
Why CoreWeave Rocketed 170% in May
CoreWeave rallied in May off of the April "liberation day" bottom. The company held its first earnings release, beating expectations and raising guidance. Nvidia disclosed that it raised its investment in the company. 10 stocks we like better than CoreWeave › Shares of CoreWeave (NASDAQ: CRWV) rocketed 169.5% in May, according to data from S&P Global Market Intelligence. CoreWeave had a busy month, not only recovering from April's "Liberation Day" along with the rest of the sector, but also holding its first earnings report since its March 28 initial public offering (IPO). Additionally, key customer and supplier Nvidia (NASDAQ: NVDA) disclosed that it had increased its investment in the company. Virtually all technology stocks and artificial intelligence (AI) stocks recovered in a big way after May 12, when the U.S. and China ratcheted down their mutual tariffs for 90 days in order to let trade talks proceed. The sky-high China tariffs had been at the heart of the worries over President Trump's tariff war, which had especially weighed on the semiconductor and AI sectors. Shortly after the rollback of China tariffs, CoreWeave also held its first-ever earnings release. In that release, CoreWeave beat revenue expectations handily. And while earnings per share missed by a lot, that was caused by one-time stock compensation costs associated with the IPO. Moreover, CoreWeave raised its revenue guidance for the year well above analyst estimates, although it also increased its outlook for capital expenditures. While investors had something of a mixed reaction to earnings, most Wall Street analysts raised their price targets afterward. But just days later, CoreWeave saw a massive spike in its stock after it was revealed that AI chip darling Nvidia had increased its investment in the company. That was followed by even larger analyst price target increases the following week. Not only did CoreWeave have a monster month of May, but the stock has also surged to begin June, following news of a 15-year, $7 billion data center expansion agreement with data center operator Applied Digital (NASDAQ: APLD). Given the massive spike in the stock price, there's a degree of meme stock momentum right now in CoreWeave. So investors should be careful with the stock at this valuation, which currently sits at about 15 times this year's revenue outlook. That's a high price for a stock with high investment needs and some substantial risks. One concern is that CoreWeave has to invest substantial amounts in fixed assets ahead of receiving revenues from its contracts. However, it appears investors are encouraged by the more aggressive growth outlook and willing to look past upfront investment needs in fixed costs that will probably require CoreWeave to raise more capital. Another risk that concerns me is the company's circular relationship with Nvidia, which is both a customer and, obviously, a key supplier. While AI demand and demand for Nvidia chips appears quite strong for now, should either demand ever slow down, CoreWeave could run into problems. Before you buy stock in CoreWeave, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and CoreWeave wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Billy Duberstein and/or his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Why CoreWeave Rocketed 170% in May was originally published by The Motley Fool
